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238Readmission in the 30 Days After Percutaneous
Coronary Intervention
Objectives This study sought to identify the frequency and etiology of readmission within 30 days
of percutaneous coronary intervention (PCI) in a large integrated healthcare system.
Background One-ﬁfth of Medicare patients are readmitted within 30 days of hospitalization. Identi-
fying the causes of readmission may help identify strategies to prevent readmission.
Methods All patients undergoing PCI (elective, urgent, and emergent) at our center between Janu-
ary 1, 2007, and April 12, 2010, were prospectively entered into the American College of Cardiology
National Cardiovascular Data Registry. Patients readmitted to any hospital within 30 days of the in-
dex procedure were identiﬁed using an administrative database and telephone follow-up. Individual
charts were reviewed independently by 2 investigators; disagreements regarding the cause for read-
mission were resolved by a third investigator.
Results During the study period, 3,255 PCI were performed, and 262 patients (8.0%) were readmit-
ed within 30 days. Of these, 261 (99.6%) had medical records available for review. Reasons for read-
ission included: complications related to the PCI (n  31, 11.9%); non-PCI cardiac causes related to
index admission (n  93, 35.6%); noncardiac causes related to index admission (n  34, 13%);
causes unrelated to the index admission (n  103, 39.5%). Multivariable logistic regression modeling
revealed that female sex, advanced age, peripheral arterial disease, prior valvular surgery, and PCI
complications during the index procedure were associated with 30-day readmission.
Conclusions Readmissions within 30 days due to complications related to PCI performed on index
admission are rare (0.9% of all PCI) and are an infrequent cause of readmission (12% of readmis-
sions). Thirty-day readmission after PCI should not be used as a quality metric of PCI performance.
(J Am Coll Cardiol Intv 2013;6:237–44) © 2013 by the American College of Cardiology Foundationw
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iReadmission after an initial hospitalization is expensive
and is associated with poor long-term outcome. One of 5
Medicare patients is readmitted within 30 days of a
hospitalization; readmissions account for approximately
one-fifth of all Medicare payments (1). After percutane-
ous coronary intervention (PCI), 30-day mortality in
patients requiring readmission following PCI is signifi-
cantly higher than in those not readmitted (2). High-
See page 245
quality care in the hospital before, during, and after a PCI
may reduce the frequency of readmission (3,4). Reducing
readmission rates may cut healthcare costs and improve
patient outcomes (5,6). Previous studies of readmission
following a PCI have used administrative databases,
which provide incomplete data (7). Individual case re-
views may yield additional data regarding causes of
readmission.
We reviewed the medical records of patients readmitted
in the 30 days following a PCI at our medical center to oidentify causes of readmission and factors that may increase
risk of readmission following PCI.
Methods
PCI center. The PCI center in this study is a 437-bed
tertiary care hospital in rural central Pennsylvania, serving
44 counties with a population of 2.6 million (8). The PCI
center is part of a health system, including 2 hospitals and
more than 40 outpatient clinics using the same integrated
electronic medical record for all inpatient and outpatient
care. Coronary intervention at the PCI center during the
study period was performed by 4 interventional cardiologists
employed by the healthcare system. All operators performed
200 PCIs per year.
Interventional procedure. PCI were typically performed
ith 6-F guide catheters via the radial or femoral approach.
ivalirudin was used for anticoagulation in most cases, and
ascular closure for femoral cases was performed using an
ntra-arterial collagen plug or suture device. In-hospital care
f the patient after the procedure was provided by cardiol-
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239ogy fellows, internal medicine residents, and advanced
practitioners under the supervision of cardiologists. A mi-
nority of patients (10%) were discharged 5 to 6 h after the
procedure (without an overnight stay) if they were identified
as being very low risk based on clinical presentation,
coronary anatomy, procedural details, laboratory values, and
social factors.
Patients. The study population included all patients under-
going PCI at our medical center from January 1, 2007, to
April 12, 2010.
Data collection. The study was approved by the institution’s
nvestigational Review Board. Data on all PCI patients
ere entered prospectively into the ACC NCDR (Ameri-
an College of Cardiology National Cardiovascular Data
egistry) at the time of the PCI by the operator and
atheterization laboratory staff. Data through hospital dis-
harge were captured by nurses and advanced practitioners.
Patients readmitted to any hospital in the health system
fter PCI were identified using the system’s electronic
ealth records. Their data were captured by chart review.
dditional follow-up was obtained using the Social Security
eath Index and telephone calls to all patients 1 year after
CI. Contact was successful in 83% and identified an
dditional 4 patients readmitted to hospitals outside of the
CI center health system. Data on the reason for readmis-
ion were available for 3 of these patients.
Medical records were reviewed independently by 2 inde-
endent investigators (S.P., G.Y.). Disagreements on the
ause of readmission were adjudicated by a third investigator
J.B.). In cases where several factors contributed to read-
ission, the principle cause was recorded. Readmissions
ere determined to be “related” versus “unrelated” by
eviewing index and readmission history, physical exam,
rogress notes, discharge summary, and medication admin-
stration reconciliation; and outpatient encounters (office
isits, telephone encounters). Any link between the index
dmission and readmission was classified as “related.” If no link
as found, the readmission was classified as “unrelated.”
Categories of readmission. Causes of readmission were cate-
orized into 4 groups: 1) PCI complications related to the PCI
rocedure; 2) cardiac causes related to the index admission; 3)
oncardiac causes related to the index admission; and 4) any
ause not related to the PCI or index admission.
DEFINITIONS OF CAUSES OF READMISSION.
1. “Gastrointestinal bleeding related to index admission”
included upper or lower gastrointestinal bleeding with
any of the following during the initial admission:
melena; hematochezia; or guaiac positive testing from
known etiologies, including peptic ulcer disease, diver-
ticulosis, angiodysplasias, hemorrhoids, or malignancy.
2. “Gastrointestinal bleeding unrelated to index admis-
sion” included upper or lower gastrointestinal bleedingafter discharge, with no evidence of bleeding during
the initial admission.
3. “Atrial fibrillation/flutter related to index admission”
included atrial fibrillation/flutter present before index
admission or occurring during the initial admission.
4. “Atrial fibrillation/flutter unrelated to index admis-
sion” included new onset of atrial fibrillation/flutter
after discharge with no past history of arrhythmia.
5. “Infections related to the index admission” included
any infections attributable to the PCI vascular access
site, Foley catheter or central venous catheter placed
during the index hospitalization, relapse of infection
acquired during the index hospitalization, exacerba-
tion of a previously identified chronic infection, or
gangrene.
6. “Infections unrelated to the index admission” included
community-acquired infections (e.g., pneumonia,
cholecystitis) in patients without evidence of infection
at any time during the index hospitalization.
7. “Neurological problems unrelated to the index admis-
sion” included seizures, syncope, transient ischemic
attack or stroke, subarach-
noid hemorrhage, or auto-
nomic dysfunction in pa-
tients without neurologic
problems at any time during
the index hospitalization.
8. “Renal insufficiency or com-
plications of end-stage renal
disease unrelated to index
admission” included read-
missions for acute kidney
injury starting 20 days
after PCI, glomerulonephropathy, or complications of
end-stage renal disease (e.g., hyperkalemia, missed
dialysis session, arteriovenous fistula malfunction).
9. “Psychiatric disorder unrelated to index admission”
included exacerbations of previous psychiatric prob-
lems that had been quiescent during the index
admission, or those newly diagnosed after the initial
admission.
Complications of PCI (using NCDR definitions) (8)
ncluded significant dissection, perforation, periprocedural
yocardial infarction, post-cardiogenic shock, congestive
eart failure, stroke, tamponade, significant bleeding, need
or transfusion, and acute renal failure requiring dialysis.
Data analysis. Demographic and procedural data for all PCI
are reported as means SD. Logistic regression was used to
compare variables between readmission and nonreadmission
groups, and p values were obtained based on empirical
standard error estimates from generalized estimating equa-
tions with exchangeable covariance structure to account for
Abbreviations
and Acronyms
CI  confidence intervals
ICD-9-CM  International
Classification of Diseases-
Ninth Revision-Clinical
Modification
OR  odds ratio
PCI  percutaneous
coronary interventionrepeated measures per patient. Variables with p value0.10
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240Table 1. Demographic and Procedural Characteristics
All
(n  3,255)
Readmitted
(n  258)
Not Readmitted
(n  2,997) p Value
Male 2,172 (66.7) 155 (60.1) 2,017 (67.3) 0.03
Age at procedure, yrs 64.0 12.1 65.7 12.9 63.9 12.0 0.03
White 3,210 (98.6) 254 (98.5) 2,956 (98.6) 0.85
BMI kg/m2; 5.3% unknown 30.8 11.0 30.5 6.7 30.6 6.6 0.37
PCI year 0.60
2007 931 (28.6) 70 (27.1) 861 (28.7)
2008 1,003 (30.8) 74 (28.7) 929 (31.0)
2009 1,016 (31.2) 90 (34.9) 926 (30.9)
2010 305 (9.4) 24 (9.3) 281 (9.4)
Smoker 1,797 (55.2) 131 (50.8) 1,666 (55.6) 0.13
Hypertension 2,326 (71.4) 193 (74.8) 2,133 (71.2) 0.18
Dyslipidemia 2,502 (76.9) 205 (79.5) 2,297 (76.6) 0.22
Family history of coronary artery disease 882 (27.1) 67 (26.0) 815 (27.2) 0.66
Prior myocardial infarction 840 (25.8) 71 (27.5) 769 (25.7) 0.42
Prior heart failure 276 (8.5) 37 (14.3) 239 (8.0) 0.004
Prior valve surgery 58 (1.8) 14 (5.4) 44 (1.5) 0.004
Prior PCI 903 (27.7) 76 (29.5) 827 (27.6) 0.31
Prior coronary artery bypass graft 489 (15.0) 50 (19.4) 439 (14.7) 0.06
Cerebrovascular disease 360 (11.1) 40 (15.5) 320 (10.7) 0.03
Peripheral artery disease 417 (12.8) 55 (21.3) 362 (12.1) 0.0004
Chronic lung disease 406 (12.5) 37 (14.3) 369 (12.3) 0.36
Diabetes mellitus 1,046 (32.1) 109 (42.3) 937 (31.3) 0.0005
Type of presentation 0.0001
STEMI presentation 816 (25.1) 61 (23.6) 755 (25.2)
Non-STEMI presentation 654 (20.1) 60 (23.3) 594 (19.8)
Unstable angina presentation 854 (26.2) 91 (35.3) 763 (25.5)
Stable angina presentation 650 (20.0) 35 (13.6) 615 (20.5)
Other presentation 281 (8.6) 11 (4.3) 270 (9.0)
Cardiogenic shock 67 (2.1) 3 (1.2) 64 (2.1) 0.17
Intra-aortic balloon pump 113 (3.5) 9 (3.5) 104 (3.5) 0.96
Fluoroscopy time, min 17.4 (11.3–25.5) 19.9 (12.3–28.6) 17.2 (11.2–25.4) 0.07
Contrast volume, ml; 6.1% unknown 225 (180–280) 230 (175–290) 225 (180–280) 0.60
Left ventricular ejection fraction, %; 29.9% unknown 55 (45–65) 55 (40–60) 55 (45–65) 0.002
Femoral arterial access 2,801 (86.1) 227 (88.0) 2,574 (85.9) 0.33
Positive stress test 582 (17.9) 30 (11.6) 552 (18.4) 0.001
PCI status 0.017
Urgent PCI status 1,385 (42.6) 128 (49.6) 1,257 (41.9)
Emergent PCI status 834 (25.6) 65 (25.2) 769 (25.7)
Elective PCI status 918 (28.2) 54 (20.9) 864 (28.8)
Other PCI status 118 (3.6) 11 (4.3) 107 (3.6)
Any procedural complication 407 (12.5) 40 (15.5) 367 (12.3) 0.16
Perforation/dissection complication 164 (5.0) 13 (5.0) 151 (5.0) 0.99
Myocardial infarction/stroke complication 108 (3.3) 14 (5.4) 94 (3.1) 0.10
Shock/heart failure/tamponade/bleeding/dialysis/
transfusion complication
176 (5.4) 18 (7.0) 158 (5.3) 0.25
1 lesion treated 873 (26.8) 69 (26.7) 904 (26.8) 0.94
Worst lesion pre-stenosis, % 90 (80–99) 90 (80–99) 90 (80–99) 0.08
“High” lesion complexity 1,651 (50.7) 139 (53.9) 1,512 (50.5) 0.30Continued on the next page
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BMI body mass index; PCI percutaneous coronary intervention; STEMI
Abbreviations as in Table 1.
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241between the 2 groups were considered for inclusion in a
multivariable logistic regression model predicting 30-day
readmission as a function of those risk factors. Using
backward stepwise elimination, a final model was obtained,
retaining variables significant at p  0.15. Results of the
logistic regression models are presented in terms of p values
and odds ratios (OR) where the OR represents the amount
by which presence of each risk factor multiplies the odds of
30-day readmission.
Results
During the study period, 3,255 PCI were performed on
2,807 patients, and 262 (8.0%) patients were readmitted
within 30 days. Data for 1 patient who had been readmitted
to an unaffiliated hospital were not available for review; this
patient was excluded from further analyses. Characteristics
of all patients who underwent PCI, and the 261 who were
readmitted, are listed in Table 1.
The reasons that patients were admitted, and their
frequencies, are listed in Table 2. Only 31 readmissions
11.9%) were due to a complication that occurred during or
fter the PCI, 93 (35.6%) were not related to the PCI but
f cardiac etiology related to the index admission, 34 (13%)
ere noncardiac but related to index admission, and 103
39.5%) were not related to the index admission (Table 2).
admitted
 258)
Not Readmitted
(n  2,997) p Value
22 (8.5) 223 (7.4) 0.52
37 (53.1) 1,505 (50.2) 0.32
40 (93.0) 2,706 (90.3) 0.09
14 (5.4) 135 (4.5) 0.53
7 (2.7) 66 (2.2) 0.63
53 (59.3) 1,610 (53.7) 0.08
 ST-segment elevation myocardial infarction.
Table 3. Elective Readmissions
Cause of Elective Readmission
Readmissions
(n  27)
Staged percutaneous coronary intervention 13
Elective coronary artery bypass graft 4
Elective carotid stenting 3
Elective peripheral artery angioplasty/stenting 3
Elective cystoscopy 1
Elective abdominal aortic aneurysm endovascular repair 1
Elective cholecystectomy 1
Scheduled bone biopsy 1Table 1. Continued
All
(n  3,255)
Re
(n
Post-stenosis 0% 245 (7.5)
Medications
Bivalirudin 1,642 (50.5) 1
Clopidogrel 2,946 (90.5) 2
Eptiﬁbatide 149 (4.6)
Glycoprotein IIb/IIIa 73 (2.2)
Heparin, unfractionated 1,763 (54.2) 1
Values are n (%), mean SD, or median (interquartile range).Table 2. Causes of Readmission
Readmission Diagnosis
Patients Readmitted, n (%)
(n  261)
PCI complications 31 (11.9)
In-stent thrombosis 12 (4.6)
Vascular access 8 (3.1)
Coronary dissection 2 (0.8)
Other 9 (3.5)
Cardiac, related to index admission 93 (35.6)
Unstable angina 28 (10.7)
Congestive heart failure 22 (8.4)
Staged PCI 13 (5.0)
Non-STEMI 9 (3.4)
Atrial ﬁbrillation/ﬂutter 5 (1.9)
Staged coronary artery bypass graft 4 (1.5)
Stable angina 4 (1.5)
Pericarditis 2 (0.8)
Hypertension crisis 2 (0.8)
Other 4 (1.5)
Noncardiac, related to index admission 32 (12.2)
Infection/sepsis 6 (2.3)
Peripheral artery disease 5 (1.9)
Carotid artery stenosis 3 (1.1)
Gastrointestinal bleed 2 (0.7)
Other 16 (6.1)
Unrelated to index admission 105 (40.2)
Noncardiac chest pain 27 (10.3)
Gastrointestinal (reﬂux, bleed, bowel obstruction) 20 (7.7)
Infection/sepsis 9 (3.4)
Neurologic 8 (3.1)
Psychiatric (anxiety, depression) 8 (3.1)
Atrial ﬁbrillation/ﬂutter (new onset) 5 (1.9)
Kidney disease (end-stage complication, missed
dialysis, acute renal insufﬁciency weeks after
index admission)
5 (1.9)
Pulmonary embolus 3 (1.1)
Orthostatic hypotension/dehydration 2 (0.7)
Chronic obstructive pulmonary disease 2 (0.7)
Other 16 (6.1)
Values are n(%). Categories listed as “other” include diagnoses with only 1 readmission.Values are n.
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242Among readmitted patients, the most common PCI
complications leading to readmission were in-stent throm-
bosis (n  12; 5% of readmissions, 0.4% of all PCI
procedures) and vascular access complications (n  8; 4
seudoaneurysms and 4 hematomas without pseudoaneu-
ysm). The most common cardiac causes for readmission
elated to the index admission (Table 3) were unstable
ngina (n  28), congestive heart failure (n  22), and
lanned readmission for a staged revascularization (n  17;
13 staged PCI, 4 staged coronary bypass surgery). The most
common noncardiac problems related to the index admis-
sion were infection (n  6), peripheral artery disease (n 
5), carotid artery stenosis (n  3), and gastrointestinal
bleeding (n  2). The most common causes of readmission
unrelated to the initial admission were noncardiac chest
pain (n  27), new gastrointestinal problems (n  20), new
infections (n  9), exacerbations of previously known
anxiety/depression (n  8), new onset atrial fibrillation or
flutter (n  5), and complications of end-stage renal disease
(n 5). Of the 261 readmitted patients with follow-up data
vailable, 27 (10%) were elective readmissions (Table 3).
Univariate analysis. Variables associated with readmission
n univariate analysis included female sex (OR: 1.34, 95%
onfidence intervals [CI]: 1.04 to 1.73, p  0.03), diabetes
ellitus (OR: 1.61, 95% CI: 1.25 to 2.08, p  0.0005),
eripheral arterial disease (OR: 1.45, 95% CI: 1.97 to 2.69,
 0.0004), and prior valve surgery (OR 3.94, CI: 2.26 to
.89, p  0.004).
Multivariate analysis. In the multivariate analysis, prior
valve surgery was the strongest risk factor for readmission
(OR: 3.72, 95% CI: 2.16 to 6.40, p  0.004) (Table 4).
Patients whose indication for PCI was unstable angina had
almost 2 times greater likelihood of readmission than those
with stable coronary disease (OR: 1.99, 95% CI: 1.33 to
3.00, p  0.0009) and those with a non–ST-segment
elevation myocardial infarction also had a much greater
Table 4. Summary of Significant Correlates of Readmission From Unadjust
Characteristic Comparator
Sex Female vs. male
Prior valve surgery
Peripheral artery disease Vs. none
Diabetes mellitus Vs. none
Pre-PCI left ventricular ejection fraction Per 10% increase
Myocardial infarction or stroke complication Vs. none
Presentation Other vs. stable angina
STEMI vs. stable angina
Non-STEMI vs. stable angina
Unstable angina vs. stable angina
Worst lesion pre-stenosis Per 10% increase
CI confidence interval; OR odds ratio; other abbreviations as in Table 1.likelihood of readmission (OR: 1.80, 95% CI: 1.15 to 2.81,p  0.01). Each 10% increase in left ventricular ejection
fraction was associated with a slightly lower likelihood of
readmission (OR: 0.94, 95% CI: 0.90 to 0.99, p  0.02),
nd each 10% increase in the pre-stenosis of the worst lesion
efore PCI was associated with a lower likelihood of
eadmission (OR: 0.85, 95% CI: 0.76 to 0.98, p  0.04).
iscussion
This is the first study of PCI readmission to use individual
chart review to identify causes of readmission and to
determine whether readmissions were related or unrelated
to the index admission. Prior studies have categorized causes
for readmission using the principle diagnosis International
Classification of Diseases-Ninth Revision-Clinical Modifi-
cation (ICD-9-CM) codes (2,3,9) or unspecified methods
(10). In contrast, we used reviews of the medical record by
2 reviewers, with a third to resolve disputes, to categorize
reason for readmission. We believe this may be a more
reliable technique, as principle diagnosis ICD-9 codes are
usually assigned by administrative rather than clinical per-
sonnel and are often inaccurate (7).
Several important findings emerged. First, readmission to
treat complications of the initial PCI was rare (0.9% of all
PCI, 11.9% of readmissions). Stent thrombosis and vascular
access complications account for the majority of these. The
relative rarity of these events may be because stent throm-
bosis has decreased substantially with newer generation
stents (11), and vascular complications decreased after the
adoption of radial access techniques at our medical center
(12). Although PCI complications have not been elimi-
nated, even their complete eradication would minimally
decrease the overall PCI readmission rate.
A second important finding of this study is the low
readmission rate of 8.0% within 30 days of PCI. Two small
single-center studies, with readmission rates of 8.5% and
Multivariate Models
Unadjusted OR
(95% CI) p Value
Adjusted OR From
Multivariate Model (95% CI) p Value
1.34 (1.04–1.73) 0.03 1.11 (0.98–1.27) 0.12
3.94 (2.26–6.89) 0.004 3.72 (2.16–6.40) 0.004
1.45 (1.97–2.69) 0.0004 1.60 (1.16–2.21) 0.01
1.61 (1.25–2.08) 0.0005 1.51 (1.16–1.97) 0.004
0.99 (0.99–0.99) 0.002 0.94 (0.90–0.99) 0.02
1.80 (1.03–3.14) 0.10 1.94 (1.11–3.41) 0.07
0.72 (0.37–1.41) 0.34 0.68 (0.35–1.34) 0.27
1.39 (0.91–2.10) 0.13 1.67 (1.06–2.65) 0.03
1.75 (1.15–2.67) 0.01 1.80 (1.15–2.81) 0.01
2.11 (1.42–4.11) 0.0002 1.99 (1.33–3.00) 0.0009
0.99 (0.98–1.00) 0.08 0.85 (0.76–0.98) 0.04ed and9.4%, were reported in 1995 and 1998 (3,10). More re-
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243cently, 2 large studies (representing all Medicare patients in
1 study and all PCI performed in New York state in the
other) reported higher readmission rates (14.6% and 15.6%)
(2,9). These studies included a large number of operators
and catheterization laboratories, some with lower volumes
and less experience, which may translate to inconsistent
quality. In contrast to these recent large studies, ours is the
only single center PCI readmission study from the modern
stent era, and it has documented much lower readmission
rates. Our lower readmission rate may be in part due to
characteristics of our health system, an integrated multispe-
cialty group practice that uses electronic medical records for
all inpatient and outpatient care, allows “read-only” access
to patients and to unaffiliated physicians, and automatically
sends reports to referring and primary care physicians. In
addition, the health system has a pharmacist-led initiative
aimed at optimizing adherence to dual antiplatelet therapy.
The lower readmission rate is not likely to be related to
differences in baseline characteristics of our population
compared with those in other studies; the incidence of
comorbidities in our patients was similar or higher than
those in prior studies. For example, 25% of our patients
presented with ST-segment elevation myocardial infarction
and 68% of PCI were urgent/emergent, which is higher
than reported in prior studies.
A third key finding of this study is that 39% of readmis-
sions were seemingly unrelated to the index admission and
were caused by illnesses not apparent during the index
admission. Whereas closer follow-up might have identified
some of these problems at an earlier stage and prevented
readmission, in the vast majority there were no obvious
lapses in care or clear-cut opportunities for improvement.
Finally, only one other study has examined the frequency
with which elective “staged” PCI procedures contributed to
readmissions after an initial PCI. In New York state, 3.4%
of all PCI patients were readmitted for a staged PCI (20%
of readmissions) (9). In contrast, only 13 patients in our
study (0.4% of all PCI and 5% of readmissions) were
readmitted for PCI. This reflects a high rate of ad hoc
multivessel PCI performed in a single setting at our hospital
(13) and, in some cases, may also reflect the performance of
elective PCI as an outpatient procedure that does not qualify
as an inpatient admission.
Thirty-day readmission rates have become a “quality
indicator” for acute myocardial infarction and congestive
heart failure, and are a National Quality Foundation pro-
posed quality indicator for PCI. The Patient Protection and
Affordable Care Act will use “quality indicators” to adjust
payment to hospitals, with decreased reimbursements di-
rectly linked to readmission rates as part of value-based
purchasing (14). In this milieu, health systems will focus
resources on preventing readmission. Analyses such as ours
may offer insight into prevention of readmission.Future efforts to prevent readmissions after PCI should
include a comprehensive interventional quality program to
decrease the rate of procedural and post-procedural compli-
cations (15). Rapid follow-up after PCI may prevent read-
missions (as has been observed for heart failure patients)
(16) by monitoring compliance with medications that pre-
vent stent thrombosis, reinfarction, and bleeding (17).
Scoring systems to predict heart failure readmissions have
been proposed (18). Data such as that included in this study
might allow development of a similar scoring system for
PCI readmissions, focusing more attention on patients at
high risk for readmission.
Study limitations. This is a single-center retrospective anal-
sis of prospectively collected data, with all the limitations
nherent in this type of study. Not all patients could be
racked in the system’s electronic medical record or con-
acted at 1 year after their PCI procedure; if patients lost to
ollow-up were sicker or were engaged in more unhealthy
ehaviors, the readmission rate might have been higher than
e identified. Case-by-case review of complications is work
ntensive, although it is associated with more accurate data
han can be gleaned from administrative databases (2,9,10).
ur categorization of readmissions as related or not related
o the index admission is subject to misclassification error
ecause, in some cases, it is difficult to determine the root
ause of the illness requiring readmission. Our study did not
dentify patients returning for acute problems that visited an
mergency department or underwent “observation status” in
hospital who in the past might have been formally
dmitted.
onclusions
Only 8.0% of patients who underwent a PCI were readmit-
ted in the 30 days after a PCI. Most factors correlating with
readmission after PCI are not modifiable (e.g., age, sex).
Readmissions within 30 days due to PCI complications are
rare (0.9% of all PCI), so eliminating all complications
would have a small effect on the overall readmission rate.
Cardiac problems related to the index admission are respon-
sible for only one-third of readmissions, and two-fifths of
readmissions appear to be unrelated to the index hospital-
ization. Our data do not support use of readmission after
PCI as an indicator of the quality of care during the index
admission.
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